These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23640951)

  • 1. Plasma vascular endothelial growth factor and angiogenin are positively related to erythropoietin dose in hemodialysis patients.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Pissas G; Galaktidou G; Stefanidis I
    Adv Med Sci; 2013; 58(1):143-9. PubMed ID: 23640951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum angiogenin level in Alzheimer's disease.
    Kim YN; Kim DH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):116-20. PubMed ID: 22449478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
    Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P
    Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients.
    Eleftheriadis T; Kartsios C; Pissas G; Liakopoulos V; Antoniadi G; Galaktidou G; Stefanidis I
    Ther Apher Dial; 2013 Feb; 17(1):48-54. PubMed ID: 23379493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma angiogenin and vascular endothelial growth factor a among hemodialysis patients.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Pissas G; Stefanidis I; Galaktidou G
    Iran J Kidney Dis; 2012 May; 6(3):209-15. PubMed ID: 22555486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.
    Abe M; Okada K; Soma M; Matsumoto K
    Clin Nephrol; 2011 Jan; 75(1):49-58. PubMed ID: 21176750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone.
    Lissoni P; Rovelli F; Baiocco N; Tangini G; Fumagalli L
    Anticancer Res; 2001; 21(1B):777-9. PubMed ID: 11299843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and angiogenin levels during fetal development and in maternal diabetes.
    Lassus P; Teramo K; Nupponen I; Markkanen H; Cederqvist K; Andersson S
    Biol Neonate; 2003; 84(4):287-92. PubMed ID: 14593238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of interleukin-10 in serum and erythropoietin sensitivity in ESRD patients on hemodialysis.
    Attia FM; Tawfik GA; Kalil KA; Mossalam MF
    Int J Lab Hematol; 2010 Oct; 32(5):524-9. PubMed ID: 20148986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte PC-1 activity in patients on maintenance haemodialysis treated with human erythropoietin and 1-alpha-D3.
    Stefanovic V; Djordjevic V; Ivic M; Mitic-Zlatkovic M; Vlahovic P
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):55-60. PubMed ID: 15802034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between red cell distribution width with erythropoietin resistance in iron replete hemodialysis patients.
    Afsar B; Saglam M; Yuceturk C; Agca E
    Eur J Intern Med; 2013 Apr; 24(3):e25-9. PubMed ID: 23246125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes.
    Kristensen PL; Pedersen-Bjergaard U; Schalkwijk C; Olsen NV; Thorsteinsson B
    Eur J Endocrinol; 2010 Sep; 163(3):391-8. PubMed ID: 20566589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor and its soluble receptor, Flt-1, are not correlated to erythropoietin in diabetics with normal or reduced renal function.
    Lenz T; Gauer S; Weich HA; Haak T; Bergner R; Gossmann J
    Nephrology (Carlton); 2005 Feb; 10(1):84-9. PubMed ID: 15705187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of hemodialysis on levels of beta-endorphin in serum of patients with chronic renal failure treated with erythropoietin].
    Burak W; Grzeszczak W; Trelewicz P; Zukowska-Szczechowska E
    Przegl Lek; 1996; 53(2):54-7. PubMed ID: 8754321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
    Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E
    Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
    Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.